A drug used to treat several blood cancers, ibrutinib, has been approved by FDA to treat chronic graft-versus-host disease, making it the first approved therapy for this potentially fatal side effect of cancer-related stem cell transplants.
http://ift.tt/2wAZLkk
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου